RESUMO
Objective:To explore the dynamic expression and migration of the novel testis- and sperm-specific protein FSCB in mouse spermatogenesis and observe the morphological localization of FSCB on normal and abnormal mouse sperm. Methods: For exactly staging of the mouse tubule sections, Periodic acid-Schiff staining was performed at first, and then the dynamic expression of FSCB on mouse testis and sperm by indirect Immunofluorescence was observed. Results:FSCB is a post meiotic protein initially expressed at step 11(stage Ⅺ)of mouse spermatogenesis in the elongating spermatids, and it’s expresson gradully become stronger and stronger from step 11(stage Ⅺ) through step 15 (stage Ⅵ). It subsequently begin migrate into the flagellar at step 15, and at last totally localize to the sperm flagellar at step 16(stage Ⅷ)accompanied with its disappearing from the cytoplasma of sperm. The exact localization of FSCB on normal sperm is in the flagellar principal piece. Its expression and localization on abnormal sperm was variablely changed:a.No expression on the whole flagellar;b. The expression segment on the flagellar was shift to near the head and become short, suggest this sperm defect middle piece;c. Its distribution on the flagellar showed beads like shape. Conclusion: FSCB is an important constituent protein of the fibrous sheath, is assembled at the surface of fibrous sheath core structure and constitutes the final assembly step of fibrous sheath at the later stages of spermiogenesis. The expression of FSCB in abnormal sperm was significantly changed. The relationship between the abnormal expression of FSCB and the sperm motility need to be further studied.
RESUMO
Objective To study the feasibility,superiority and curative effect of percutaneous nephrolithotomy with fibrous sheath and Swiss LithoClast Master (EMS Ⅲ) through T-tube tract for retained choledocholithiasis. Methods This study involved 32 patients with hepatolithiasis who were treated in our hospital from August 2004 to August 2007. By combining percutaneous nephrolithotomy (with a fibrous sheath on) and Swiss LithoClast Master (EMS Ⅲ) through a T-tube tract,retained choledocholithiasis was removed. Results The 32 patients totally underwent 36 operations. The mean operation time was 43 minutes (ranged from 33 to 78 minutes). In 28 of the cases,the stones were extracted completely by one session; and 2 were cured by two operations. The final stone-free rate was 94% (30/32). Follow-up was carried out in all the patients for 26 to 48 months (mean,29 months),during which no patients developed abdominal pain,jaundice or fever,no recurrence was detected by B-ultrasonography. Two patients showed residual stones after the treatment,one of them received Roux-en-Y hepatocholangioenterostomy because of extensive multiple biliary stones in the liver,which could no be removed completely after three sessions of nephrolithotomy; another patient who was a 70-year old man refused the secondary operation and thus retained a few stones in the right inferior lobe of the liver. In this series of 32 cases,no bile duct tear,massive hemorrhage,biliary leakage,cholangitis or abdominal distension occurred. Conclusions It is a safe,convenient,and simple method to combine percutaneous nephrolithotomy with Swiss LithoClast Master via T-Tube tract for retained choledocholithiasis. The procedure results in less pain in patients,and reduced equipment spoilage,while the cost is low. As the surgery is easy to perform,it is worth being widely used.